Citadel Advisors’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.9K | Sell |
54,039
-28,084
| -34% | -$47.7K | ﹤0.01% | 5302 |
|
|
2025
Q1 | $130K | Sell |
82,123
-76,918
| -48% | -$122K | ﹤0.01% | 5047 |
|
|
2024
Q4 | $285K | Buy |
159,041
+130,562
| +458% | +$234K | ﹤0.01% | 4565 |
|
|
2024
Q3 | $173K | Buy |
28,479
+3,354
| +13% | +$20.3K | ﹤0.01% | 4709 |
|
|
2024
Q2 | $132K | Sell |
25,125
-11,393
| -31% | -$59.9K | ﹤0.01% | 4839 |
|
|
2024
Q1 | $310K | Sell |
36,518
-227,089
| -86% | -$1.93M | ﹤0.01% | 4363 |
|
|
2023
Q4 | $1.74M | Buy |
263,607
+258,132
| +4,715% | +$1.7M | ﹤0.01% | 2519 |
|
|
2023
Q3 | $16.9K | Sell |
5,475
-5,408
| -50% | -$16.7K | ﹤0.01% | 5342 |
|
|
2023
Q2 | $29.4K | Buy |
+10,883
| New | +$29.4K | ﹤0.01% | 5151 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6064 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6196 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6092 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6239 |
|
|
2022
Q1 | – | Sell |
-483,897
| Closed | -$6.87M | – | 6540 |
|
|
2021
Q4 | $6.87M | Sell |
483,897
-201,634
| -29% | -$2.86M | ﹤0.01% | 1825 |
|
|
2021
Q3 | $5.49M | Sell |
685,531
-35,170
| -5% | -$281K | ﹤0.01% | 1965 |
|
|
2021
Q2 | $20.6M | Buy |
720,701
+234,042
| +48% | +$6.69M | ﹤0.01% | 934 |
|
|
2021
Q1 | $14.1M | Buy |
486,659
+85,047
| +21% | +$2.47M | ﹤0.01% | 1180 |
|
|
2020
Q4 | $4.79M | Sell |
401,612
-732
| -0.2% | -$8.73K | ﹤0.01% | 1813 |
|
|
2020
Q3 | $2.78M | Buy |
+402,344
| New | +$2.78M | ﹤0.01% | 1975 |
|
|
2018
Q2 | – | Sell |
-2,682
| Closed | -$10K | – | 4272 |
|
|
2018
Q1 | $10K | Buy |
2,682
+603
| +29% | +$2.25K | ﹤0.01% | 3915 |
|
|
2017
Q4 | $9K | Sell |
2,079
-1,092
| -34% | -$4.73K | ﹤0.01% | 3813 |
|
|
2017
Q3 | $18K | Buy |
3,171
+2,228
| +236% | +$12.6K | ﹤0.01% | 3538 |
|
|
2017
Q2 | $10K | Buy |
+943
| New | +$10K | ﹤0.01% | 3580 |
|